RPG Life Sciences Limited (RPGLIFE.NS)
INR 2267.75
(3.54%)
INR 2267.75
(3.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 876.6 Million INR | 29.6% |
| 2022 | 676.4 Million INR | 31.39% |
| 2021 | 514.8 Million INR | 28.7% |
| 2020 | 400 Million INR | 37.88% |
| 2019 | 290.1 Million INR | 168.36% |
| 2018 | 108.1 Million INR | -19.63% |
| 2017 | 134.5 Million INR | -34.26% |
| 2016 | 204.6 Million INR | 76.08% |
| 2015 | 116.2 Million INR | 1062.0% |
| 2014 | 10 Million INR | -98.13% |
| 2013 | 534 Million INR | 1110.88% |
| 2012 | 44.1 Million INR | 418.82% |
| 2011 | 8.5 Million INR | -93.31% |
| 2010 | 127.12 Million INR | 17.75% |
| 2009 | 107.96 Million INR | 63.39% |
| 2008 | 66.07 Million INR | 10.99% |
| 2007 | 59.53 Million INR | -25.93% |
| 2006 | 80.37 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 267.6 Million INR | 102.11% |
| 2023 Q2 | 258.6 Million INR | 17.01% |
| 2023 Q1 | 221 Million INR | 113.53% |
| 2023 FY | 876.6 Million INR | 29.6% |
| 2023 Q4 | 132.4 Million INR | -49.96% |
| 2023 Q3 | 264.6 Million INR | 2.32% |
| 2022 Q2 | 199.7 Million INR | 9.67% |
| 2022 Q4 | 103.5 Million INR | -45.84% |
| 2022 FY | 676.4 Million INR | 31.39% |
| 2022 Q1 | 182.1 Million INR | 142.15% |
| 2022 Q3 | 191.1 Million INR | -4.31% |
| 2021 Q4 | 75.2 Million INR | -48.6% |
| 2021 Q2 | 157.5 Million INR | 15.98% |
| 2021 Q3 | 146.3 Million INR | -7.11% |
| 2021 FY | 514.8 Million INR | 28.7% |
| 2021 Q1 | 135.8 Million INR | 96.24% |
| 2020 Q2 | 111.5 Million INR | 23.07% |
| 2020 FY | 400 Million INR | 37.88% |
| 2020 Q3 | 128.7 Million INR | 15.43% |
| 2020 Q4 | 69.2 Million INR | -46.23% |
| 2020 Q1 | 90.6 Million INR | 204.03% |
| 2019 Q2 | 97.7 Million INR | 17.01% |
| 2019 FY | 290.1 Million INR | 168.36% |
| 2019 Q4 | 29.8 Million INR | -62.33% |
| 2019 Q3 | 79.1 Million INR | -19.04% |
| 2019 Q1 | 83.5 Million INR | 442.21% |
| 2018 Q2 | 21.6 Million INR | 18.03% |
| 2018 Q1 | 18.3 Million INR | 46.4% |
| 2018 Q3 | 52.8 Million INR | 144.44% |
| 2018 Q4 | 15.4 Million INR | -70.83% |
| 2018 FY | 108.1 Million INR | -19.63% |
| 2017 FY | 134.5 Million INR | -34.26% |
| 2017 Q3 | 54.6 Million INR | -13.47% |
| 2017 Q4 | 12.5 Million INR | -77.11% |
| 2017 Q1 | 4.3 Million INR | 304.76% |
| 2017 Q2 | 63.1 Million INR | 1367.44% |
| 2016 Q4 | -2.1 Million INR | -138.18% |
| 2016 Q3 | 5.5 Million INR | -94.63% |
| 2016 Q2 | 102.5 Million INR | 3.85% |
| 2016 FY | 204.6 Million INR | 76.08% |
| 2016 Q1 | 98.7 Million INR | 338.67% |
| 2015 Q4 | 22.5 Million INR | -51.82% |
| 2015 Q2 | 25.6 Million INR | 19.63% |
| 2015 Q3 | 46.7 Million INR | 82.42% |
| 2015 Q1 | 21.4 Million INR | -54.47% |
| 2015 FY | 116.2 Million INR | 1062.0% |
| 2014 Q1 | 11.6 Million INR | 327.45% |
| 2014 Q4 | 47 Million INR | 85.77% |
| 2014 Q3 | 25.3 Million INR | 134.24% |
| 2014 Q2 | -73.9 Million INR | -737.07% |
| 2014 FY | 10 Million INR | -98.13% |
| 2013 Q3 | -30.2 Million INR | -234.82% |
| 2013 Q1 | 546.9 Million INR | 639.05% |
| 2013 Q2 | 22.4 Million INR | -95.9% |
| 2013 Q4 | -5.1 Million INR | 83.11% |
| 2013 FY | 534 Million INR | 1110.88% |
| 2012 Q1 | 27.9 Million INR | 0.0% |
| 2012 FY | 44.1 Million INR | 418.82% |
| 2012 Q3 | -60.9 Million INR | -2064.52% |
| 2012 Q2 | 3.1 Million INR | -88.89% |
| 2012 Q4 | 74 Million INR | 221.51% |
| 2011 FY | 8.5 Million INR | -93.31% |
| 2010 FY | 127.12 Million INR | 17.75% |
| 2009 FY | 107.96 Million INR | 63.39% |
| 2008 FY | 66.07 Million INR | 10.99% |
| 2007 FY | 59.53 Million INR | -25.93% |
| 2006 FY | 80.37 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sigachi Industries Limited | 571.8 Million INR | -53.305% |
| Ind-Swift Limited | 142.31 Million INR | -515.966% |
| Bajaj HealthCare Limited | -837.93 Million INR | 204.615% |
| Sakar Healthcare Limited | 116.7 Million INR | -651.099% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 97.237% |
| Innova Captab Limited | 943.45 Million INR | 7.086% |
| Divi's Laboratories Limited | 16 Billion INR | 94.521% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 45.725% |
| Morepen Laboratories Limited | 961.59 Million INR | 8.839% |
| Mankind Pharma Limited | 19.12 Billion INR | 95.417% |
| Sequent Scientific Limited | -358.69 Million INR | 344.389% |
| Wanbury Limited | 559.56 Million INR | -56.658% |
| Laurus Labs Limited | 1.6 Billion INR | 45.4% |
| Nectar Lifesciences Limited | 49.95 Million INR | -1654.955% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 81.384% |
| Alembic Limited | 2.68 Billion INR | 67.366% |
| Hikal Limited | 696 Million INR | -25.948% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 85.765% |
| Neuland Laboratories Limited | 3 Billion INR | 70.788% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 84.138% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 105.838% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 34.791% |
| Themis Medicare Limited | 435.23 Million INR | -101.407% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 97.729% |
| Lupin Limited | 19.14 Billion INR | 95.421% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -94.919% |
| Wockhardt Limited | -4.63 Billion INR | 118.933% |
| Vaishali Pharma Limited | 7.18 Million INR | -12093.629% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 59.585% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -290.242% |
| Jubilant Pharmova Limited | 771 Million INR | -13.696% |
| FDC Limited | 3.05 Billion INR | 71.28% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 98.426% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -500.353% |
| Eris Lifesciences Limited | 3.91 Billion INR | 77.637% |
| Venus Remedies Limited | 284.9 Million INR | -207.678% |
| ZIM Laboratories Limited | 172.46 Million INR | -408.28% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -16.177% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -504.51% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 80.822% |
| Shilpa Medicare Limited | 318.74 Million INR | -175.019% |
| Albert David Limited | 754.2 Million INR | -16.229% |
| Ajanta Pharma Limited | 8.16 Billion INR | 89.26% |
| Hester Biosciences Limited | 188.89 Million INR | -364.08% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 70.807% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 115.45% |
| Gufic Biosciences Limited | 861.35 Million INR | -1.77% |
| Windlas Biotech Limited | 581.87 Million INR | -50.652% |
| Procter & Gamble Health Limited | 2 Billion INR | 56.384% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -1771.61% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 1066.302% |
| Granules India Limited | 4.05 Billion INR | 78.372% |
| Aarti Drugs Limited | 1.71 Billion INR | 48.862% |
| Bal Pharma Limited | 73.92 Million INR | -1085.845% |
| Alkem Laboratories Limited | 17.95 Billion INR | 95.119% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.085% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | 6.05% |
| Medicamen Biotech Limited | 109.31 Million INR | -701.939% |
| Unichem Laboratories Limited | -704.74 Million INR | 224.386% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -1092.994% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -12260.406% |
| Valiant Laboratories Limited | 3.19 Million INR | -27328.035% |
| Orchid Pharma Limited | 921.66 Million INR | 4.89% |
| Medico Remedies Limited | 82.9 Million INR | -957.304% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 79.176% |
| Ipca Laboratories Limited | 5.47 Billion INR | 83.985% |
| Brooks Laboratories Limited | -195.91 Million INR | 547.43% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -246.288% |
| Piramal Enterprises Limited | -16.83 Billion INR | 105.207% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 94.708% |
| NATCO Pharma Limited | 13.88 Billion INR | 93.686% |
| Suven Life Sciences Limited | -1.05 Billion INR | 183.425% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 544.334% |
| Strides Pharma Science Limited | -706.14 Million INR | 224.14% |
| Indoco Remedies Limited | 984.6 Million INR | 10.969% |
| Alpa Laboratories Limited | 167.76 Million INR | -422.517% |
| Lasa Supergenerics Limited | -217.3 Million INR | 503.394% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 122.639% |